Endocrine disease marked by high blood sugar
A Brazilian study links high intake of artificial sweeteners to faster cognitive decline over eight years, especially among those under 60. The study analyzed seven sweeteners and tracked nearly 13,000 participants, finding the highest-intake group aged 52 showed a 62% faster decline in mental performance versus the lowest intake group.
Novo Nordisk has filed a US lawsuit accusing Eli Lilly of false advertising over weight‑loss and diabetes drugs, arguing Lilly used outdated trial data to claim superiority. Lilly defends its campaigns, citing SURMOUNT‑5 results. The case centers on GLP-1 treatments and the race for market dominance, with potential damages and corrective advertising at stake.
Federal SNAP reform has tightened eligibility and shifted costs to states, triggering a sharp drop in participation and putting pressure on food banks. Arizona records the largest decline, with state processes becoming more burdensome and delivery times longer as programs adjust. Projections warn of continued reductions without congressional action.
A nationwide Taiwan study shows that when a spouse develops dementia, the other is more likely to receive the diagnosis too. Women face a 74% higher relative risk; men 69%. Absolute five-year risk remains modest but higher than peers without a partner with dementia.
Recent reporting shows chronic inflammation is linked to aging disorders such as cancer and Alzheimer’s. Studies indicate inflammation may be a cause, not just a symptom, of broad health risks. Policy and lifestyle factors are under scrutiny as researchers push for preventative strategies.
Foundayo, the oral GLP-1 weight-loss pill by Eli Lilly, has been authorised by the MHRA for weight management and type 2 diabetes. It will be available privately; NHS adoption depends on NICE evaluation. Several UK outlets report on uptake, pricing, side effects and competing pills, including Wegovy and Wegovy HD.
Starbucks and Bank of America are recalibrating GLP-1 weight-loss drug coverage amid rising costs. Starbucks will exclude GLP-1s for weight loss from October for benefits-eligible employees; Bank of America says its GLP-1 program costs exceed $250 million annually and accounts for about 13% of healthcare spend. Other firms weigh limits as utilization climbs.
NHS services face ongoing summer pressures as heatwaves intensify, with A&E attendances rising and infrastructure strains highlighted by officials. Hospitals report equipment failures in heat, and authorities warn of greater risks to the vulnerable as climate-related health demands grow.
Employers increasingly monitor workers using digital tools first deployed during the pandemic. A wave of tracking spans location, productivity, communications, and device access, creating detailed dossiers that can punish or predict behavior. Pharmacist Lannie Duong’s case illustrates how hours, calls, and appointments are quantified, fueling burnout and union organizing.
A wave of studies finds that AI analysis of mammograms can identify cardiovascular risks in women, including hypertension, coronary heart disease and stroke, alongside breast cancer screening. Researchers say mammograms could become a dual-purpose tool for early cardiovascular risk detection, prompting earlier intervention.
Dietitians highlight the health benefits of fiber and list high-fiber foods to boost gut health, with a focus on whole grains, beans, and plant-based meals. The conversations emphasize practical ways to reach 40–60 grams daily, citing research and expert opinion.
A government-commissioned review has found that care leavers aged 18-24 die at three to four times the rate of their peers, with 18-year-olds facing a cliff in support. The report calls for a national overhaul of housing, personal advisers and mental health support as ministers pledge a £25m commitment to connected housing.
A Berlin-led study presented at the ESC Congress finds higher blood levels of xylitol are associated with increased risk of major cardiovascular events. The association is dose-dependent and persists across age and risk factors, prompting calls for further research.
A study from Anglia Ruskin University finds traditional dieting is less effective for men, who view dieting as restrictive and feminine. Partners often support men, while male-focused programmes that emphasize quick wins, social competition and strength may boost engagement. Researchers advocate practical, non-dieting strategies and sport-related challenges.
Lawsuits allege GLP-1 diabetes drugs may cause nonarteritic anterior ischemic optic neuropathy (NAION), an eye condition that can cause permanent vision loss. Novo Nordisk and Eli Lilly dispute the claims as regulators review data; meanwhile trials and studies show mixed signals about risk.
Israeli society continues to face escalating mental health challenges three years after the October 7 attacks, with PTSD, anxiety and sleep disorders rising among children, evacuees and the broader population. New data from Clalit Health Services and other researchers show sustained strain, increased psychiatric emergencies, and shifting healthcare needs as the war persists.